Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

Last month, the World Health Organization (WHO) estimated it would take 18 months to develop a vaccine for the novel coronavirus (COVID-19). Here is an update on the progress of several major ...

COVID-19 brought unprecedented public attention to the development, regulation, and timeline for products that prevent deadly infections, potentially heralding an era of vaccine innovation marked ...

Pfizer received FDA approval to enroll adolescents in its COVID-19 vaccine trial. Experts say it's an important step aimed at determining whether a vaccine could be safe and effective in children.

Development of new coronavirus vaccines may be hitting critical mass. Here’s how they work By Maggie Fox, CNN 8 minute read ...

Many of the vaccines that are in development for COVID-19 were made possible because researchers had seed funding for technologies that make rapid vaccine development possible. That funding came from ...

Covid-19 vaccine stocks are back in focus, as cases in the U.S. surge with the spread of the highly infectious Delta variant of the virus. The seven-day average for Covid-19 cases stood at around ...

As COVID-19 continues to spread across the U.S., impacting our daily lives and creating an uncertain future, the world eagerly awaits a vaccine – something that is likely 12 to 18 months away.

Covid-19 vaccine stocks are back in focus, as cases in the U.S. surge with the spread of the highly infectious Delta variant of the virus. The seven-day average for Covid-19 cases stood at around ...